{"disease":{"id":"pseudobulbar-affect","name":"Pseudobulbar affect","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":2,"pipeline_drug_count":0,"trial_count":0},"drugs":{"marketed":[{"drug_id":"quinidine-sulfate","indication_name":"Pseudobulbar affect","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Quinidine Gluconate","generic_name":"QUINIDINE SULFATE","company_name":"Eli Lilly","drug_phase":"marketed","molecular_target":"Muscarinic acetylcholine receptor M2","drug_class":"Antiarrhythmic","quality_score":10,"revenue":null,"mechanism":"Quinidine Gluconate works by blocking the M2 muscarinic acetylcholine receptor, which helps regulate heart rhythm."},{"drug_id":"dextromethorphan","indication_name":"Pseudobulbar affect","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Delsym","generic_name":"dextromethorphan","company_name":"Generic (originally Roche)","drug_phase":"marketed","molecular_target":"Taste receptor type 2 member 46, Solute carrier family 22 member 1, Cytochrome P450 2D6","drug_class":"Antitussive (non-opioid)","quality_score":40,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":2,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06396260","title":"Structural and Functional Networks in ALS: An Insight Into Pseudobulbar Affect","phase":"NA","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"Aalborg University Hospital","has_results":false},{"nct_id":"NCT01832350","title":"Nuedexta in the Treatment of Pseudobulbar Affect in Patients With Alzheimer's Disease","phase":"PHASE4","overall_status":"TERMINATED","enrollment_count":34,"lead_sponsor_name":"St. Joseph's Hospital and Medical Center, Phoenix","has_results":false},{"nct_id":"NCT06457126","title":"Piloting the Attention Training Technique for Post-Stroke Emotionalism","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":14,"lead_sponsor_name":"University of Manchester","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}